Breaking News Instant updates and real-time market news.

SNY

Sanofi

$39.91

0.19 (0.48%)

13:04
02/19/18
02/19
13:04
02/19/18
13:04

Tuberculosis vaccine trial results offer potential for new BCG strategies

Aeras announced results from an innovative clinical trial that provides encouraging new evidence that Tuberculosis vaccines could prevent sustained infections in high-risk adolescents. In a prevention-of-infection Phase 2 trial conducted in South Africa, revaccination with the Bacille Calmette-Guerin vaccine significantly reduced sustained TB infections in adolescents. An experimental vaccine candidate, H4:IC31, also reduced sustained infections, although not at statistically significant levels. However, the trend observed for H4:IC31 is the first time a subunit vaccine has shown any indication of ability to protect against TB infection or disease in humans. TB infections that developed during the study were determined using a QuantiFERON-TB Gold in Tube test, a commercially available blood test that helps diagnose TB infections. In the trial, individuals who tested negative for QFT-GIT were considered to not have a TB infection. The trial measured the rate by which individuals converted to QFT-GIT positive, implying evidence of TB infection. Those individuals who tested QFT-GIT positive consecutively over 6 months were considered to have a sustained infection. The study evaluated H4:IC31 vaccination and BCG revaccination for safety, immunogenicity and the ability to prevent initial and sustained TB infections among healthy adolescents in the Western Cape Province of South Africa. H4:IC31 is an investigative subunit vaccine candidate being developed jointly by Aeras and Sanofi Pasteur, the vaccines business of Sanofi, and the Statens Serum Institut. BCG is the only licensed tuberculosis vaccine available globally.

  • 08

    Mar

  • 25

    Mar

  • 02

    May

SNY Sanofi
$39.91

0.19 (0.48%)

01/24/18
FBCO
01/24/18
NO CHANGE
Target $105
FBCO
Neutral
Bioverativ price target raised to $105 from $65 at Credit Suisse
Credit Suisse analyst Martin Auster raised his price target for Bioverativ (BIVV) to $105 from $65 ahead of likely closing of the Sanofi (SNY) deal. The analyst reiterates a Neutral rating on Bioverativ's shares.
01/24/18
ARGS
01/24/18
DOWNGRADE
ARGS
Hold
Bioverativ downgraded to Hold from Buy at Argus
Argus analyst Jasper Hellweg downgraded Bioverativ (BIVV) to Hold from Buy after the company announced a deal to be acquired by Sanofi (SNY) for $105 per share in cash. Hellweg says the strong run-up in the stock and the forthcoming acquisition have fully valued the stock at current levels.
02/08/18
BERN
02/08/18
NO CHANGE
Target $45
BERN
Market Perform
Sanofi price target lowered to $45 from $50 at Bernstein
Bernstein analyst Tim Anderson lowered his price target for Sanofi to $45 from $50 following a "weak" quarter. The analyst reiterates a Market Perform rating on the shares.
02/19/18
JEFF
02/19/18
NO CHANGE
Target $145
JEFF
Buy
AnaptysBio price target raised to $145 from $101 at Jefferies
Jefferies analyst Biren Amin raised his price target for AnaptysBio (ANAB) to $145 after the company presented final data from its Phase IIa trial of ANB020 in 12 mod-to-severe adult atopic dermatitis patients. The shares closed Friday up $6.59, of 5.5%, to $126.45. Sustained efficacy on a single dose of '020 was seen up to day 78 at EASI-50 in 75% of patients, comparable to Phase II data from Sanofi (SNY) and Regeneron (REGN) competitor Dupixent, Amin tells investors in a research note. ANB020 beats if you account for single dose versus Q2 weeks of Dupi, the analyst contends. He keeps a Buy rating on AnaptysBio.

TODAY'S FREE FLY STORIES

CZZ

Cosan

$8.32

0.105 (1.28%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Downgrade
Cosan rating change  »

Cosan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

, CYH

Community Health

$2.72

-0.055 (-1.99%)

09:32
07/23/18
07/23
09:32
07/23/18
09:32
Recommendations
LifePoint, Community Health, Apollo Global, HCA Healthcare analyst commentary  »

Deal activity could pick…

LPNT

LifePoint

$47.85

-0.75 (-1.54%)

CYH

Community Health

$2.72

-0.055 (-1.99%)

APO

Apollo Global

$35.39

-0.22 (-0.62%)

HCA

HCA Healthcare

$108.01

0.31 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Jul

  • 27

    Jul

  • 02

    Aug

  • 22

    Aug

BIDU

Baidu

$260.00

-2.32 (-0.88%)

09:31
07/23/18
07/23
09:31
07/23/18
09:31
Downgrade
Baidu rating change  »

Baidu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

SLM

Sallie Mae

$11.71

-0.11 (-0.93%)

, CHGG

Chegg

$29.07

-0.07 (-0.24%)

09:31
07/23/18
07/23
09:31
07/23/18
09:31
Hot Stocks
Sallie Mae, Chegg introduce enhanced Study Starter benefit »

Sallie Mae (SLM) and…

SLM

Sallie Mae

$11.71

-0.11 (-0.93%)

CHGG

Chegg

$29.07

-0.07 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

09:30
07/23/18
07/23
09:30
07/23/18
09:30
Hot Stocks
Trump calls U.S. Post Office Amazon's 'delivery boy' at fraction of cost »

President Trump tweeted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:29
07/23/18
07/23
09:29
07/23/18
09:29
Hot Stocks
Halliburton says sees international business better in 2H18 »

Says seeing ramp up in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BV

BrightView

$21.95

0.14 (0.64%)

09:29
07/23/18
07/23
09:29
07/23/18
09:29
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:28
07/23/18
07/23
09:28
07/23/18
09:28
Hot Stocks
Halliburton says sees Q3 effective tax rate approximately 20% »

Says expects go generate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BSX

Boston Scientific

$33.77

0.06 (0.18%)

, SYK

Stryker

$174.33

1.44 (0.83%)

09:26
07/23/18
07/23
09:26
07/23/18
09:26
Recommendations
Boston Scientific, Stryker analyst commentary  »

Boston Scientific price…

BSX

Boston Scientific

$33.77

0.06 (0.18%)

SYK

Stryker

$174.33

1.44 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 14

    Aug

  • 15

    Aug

HAS

Hasbro

$94.02

0.38 (0.41%)

09:26
07/23/18
07/23
09:26
07/23/18
09:26
Hot Stocks
Hasbro says 30% of manufacturing is outside of China »

Says biggest percentage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BV

BrightView

$21.95

0.14 (0.64%)

09:23
07/23/18
07/23
09:23
07/23/18
09:23
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

, AUDVF

Audi AG

$0.00

(0.00%)

09:22
07/23/18
07/23
09:22
07/23/18
09:22
Periodicals
VW board member wary of 'humiliating' Audi's Stadler, FT reports »

Hiltrud Werner, a top…

VLKAY

Volkswagen

$0.00

(0.00%)

AUDVF

Audi AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$33.77

0.06 (0.18%)

09:21
07/23/18
07/23
09:21
07/23/18
09:21
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 14

    Aug

  • 15

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:21
07/23/18
07/23
09:21
07/23/18
09:21
Earnings
Halliburton says sees Q3 earnings 'similar' to Q2 »

Says temporary challenges…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

09:20
07/23/18
07/23
09:20
07/23/18
09:20
General news
U.S. Sentiment Strength Extends into July: »

U.S. Sentiment Strength…

MU

Micron

$55.01

-1.2 (-2.13%)

, QCOM

Qualcomm

$58.62

-0.7 (-1.18%)

09:19
07/23/18
07/23
09:19
07/23/18
09:19
Recommendations
Micron, Qualcomm, AMD, Intel, Nvidia, Microchip, Texas Instruments, Marvell, Analog Devices, Cypress Semiconductor analyst commentary  »

Tariff uncertainty a…

MU

Micron

$55.01

-1.2 (-2.13%)

QCOM

Qualcomm

$58.62

-0.7 (-1.18%)

AMD

AMD

$16.49

-0.22 (-1.32%)

INTC

Intel

$51.92

-0.09 (-0.17%)

NVDA

Nvidia

$250.87

-1.15 (-0.46%)

MCHP

Microchip

$94.39

-0.46 (-0.48%)

TXN

Texas Instruments

$114.99

0.34 (0.30%)

MRVL

Marvell

$21.85

0.14 (0.64%)

ADI

Analog Devices

$97.81

-0.46 (-0.47%)

CY

Cypress Semiconductor

$17.06

-0.09 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 07

    Aug

  • 14

    Aug

  • 16

    Aug

HAL

Halliburton

$45.23

0.26 (0.58%)

09:18
07/23/18
07/23
09:18
07/23/18
09:18
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

HAL

Halliburton

$45.23

0.26 (0.58%)

09:18
07/23/18
07/23
09:18
07/23/18
09:18
Hot Stocks
Breaking Hot Stocks news story on Halliburton »

Halliburton says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
07/23/18
07/23
09:18
07/23/18
09:18
Options
Overnight activity included 89 trades in SPX and 3 trades in VIX »

89 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$45.23

0.26 (0.58%)

09:17
07/23/18
07/23
09:17
07/23/18
09:17
Hot Stocks
Halliburton says expects international markets to improve in coming quarters »

Says "better…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

MSFT

Microsoft

$106.29

1.59 (1.52%)

09:16
07/23/18
07/23
09:16
07/23/18
09:16
Conference/Events
Microsoft to hold a summit »

Microsoft Business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 08

    Aug

  • 04

    Sep

HAL

Halliburton

$45.23

0.26 (0.58%)

09:13
07/23/18
07/23
09:13
07/23/18
09:13
Hot Stocks
Halliburton says activity improved in all geographic markets in Q2 »

Says mindful of of impact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

09:13
07/23/18
07/23
09:13
07/23/18
09:13
General news
Trump is 'very happy,' says 'Japan is happy, all of Asia is happy' »

President Trump just…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMP

Adamis Pharmaceuticals

$3.80

0.125 (3.40%)

09:11
07/23/18
07/23
09:11
07/23/18
09:11
Hot Stocks
Adamis Pharmaceuticals adds sublingual ED product candidate to pipeline »

Adamis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.